Stefan Zastrow

Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study

Klaus‐Peter Dieckmann, Arlo Radtke, Lajos Géczi et al. · Journal of Clinical Oncology · 2019 · 330 citations · Full text

Vaccination of hormone‐refractory prostate cancer patients with peptide cocktail‐loaded dendritic cells: Results of a phase I clinical trial

Susanne Fuessel, Axel Meye, Marc Schmitz et al. · The Prostate · 2006 · 125 citations

Cisplatin, methotrexate and bleomycin for treating advanced penile carcinoma

Oliver W. Hakenberg, Johannes Nippgen, Michael Froehner et al. · British Journal of Urology · 2006 · 114 citations

CD31, EDNRB and TSPAN7 are promising prognostic markers in clear‐cell renal cell carcinoma revealed by genome‐wide expression analyses of primary tumors and metastases

Daniela Wuttig, Stefan Zastrow, S. Füssel et al. · International Journal of Cancer · 2011 · 112 citations

Renal Pathology, Pathology, Genome‐wide Expression Analyses +18

Features Associated with Recurrence Beyond 5 Years After Nephrectomy and Nephron-Sparing Surgery for Renal Cell Carcinoma: Development and Internal Validation of a Risk Model (PRELANE score) to Predict Late Recurrence Based on a Large Multicenter Database (CORONA/SATURN Project)

Sabine Brookman‐May, Matthias May, Shahrokh F. Shariat et al. · European Urology · 2012 · 104 citations · Full text

Urology, Surgical Oncology, Risk Model +10